Table 1.
Characteristic | Patients (N = 22) |
---|---|
Age, y, median (range) | 62 (23–84) |
Gender, n (%) | |
Female | 9 (41) |
Male | 13 (59) |
Race, n (%) | |
White | 16 (73) |
Black | 6 (27) |
AJCC pathologic stage, n (%) | |
I | 2 (9) |
II | 4 (18) |
III | 6 (27) |
IV | 10 (46) |
Tumor location and histology, n (%) | |
Oral cavity SCC | 8 (36) |
Facial skin cutaneous | 4 (18) |
Major salivary gland | 3 (14) |
Maxillary sinus SCC | 3 (14) |
Oropharynx SCC | 2 (9) |
Larynx SCC | 1 (5) |
CN 11 MPNST | 1 (5) |
Ablation surgery, n (%) | |
Glossectomy | 4 (18) |
Mandibulectomy | 4 (18) |
Skin or soft-tissue resection | 4 (18) |
Maxillectomy | 3 (14) |
Pharyngectomy | 2 (9) |
Othera | 5 (23) |
Reconstructive surgery, n (%) | |
Free tissue transfer | 15 (68) |
Local flap | 3 (14) |
Skin graft | 3 (14) |
Primary closure | 1 (5) |
Adjuvant therapy, n (%) | |
Yes | 16 (73) |
No | 6 (27) |
Follow-up, months from surgery, median (range) | 5 (1–21) |
Abbreviations: AJCC, American Joint Committee on Cancer; CN, cranial nerve; MPNST, malignant peripheral nerve sheath tumor; SCC, squamous cell carcinoma.
ã Total laryngectomy (n = 1), resection of CN 11 malignant peripheral nerve sheath tumor (n = 1), radical parotidectomy (n = 1), submandibular gland and oral cavity composite resection (n = 1), submandibular gland and skin composite resection (n = 1).